RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
AxiomX Inc Next-generation antibody development platform. Acquisition

MOST ACTIVE INVESTORS

Abcam PLC US 1
Vital Venture Capital US 1

MOST ACTIVE ACQUIRERS

Abcam PLC US 1

BEST FUNDED


Next-generation antibody development platform.